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 T-cell transformation is an ever-expanding treatment for several types of cancer, with a 
potential to be adapted to other disorders in which the immune system plays a key role in the 
pathophysiology. Currently, all FDA approved chimeric antigen receptor (CAR) T-cell cancer 
therapies rely on transformation via viral transduction. However, viral transduction is plagued by 
poor consistency and the potential to create adverse immune reactions when T-cells are 
reintroduced into a patient. Other transformation methods are being explored, with an alternative 
called acoustofluidic sonoporation showing promise. In these procedures, cells are passed through 
a channel, of the millimeter scale, while ultrasound (US) is applied. The US causes unstable 
cavitation of perfluorocarbon microbubbles (MBs) resulting in rupture that reversibly 
permeabilizes cells, allowing entry of almost any water-soluble biologic (e.g. DNA/RNA, small 
molecules, etc.). While current research demonstrates that acoustofluidic sonoporation may be 
better than other transfection methods, there is a limited understanding of the fluid dynamics within 
the acoustofluidic devices and the physical mechanisms of the alteration in cell permeability. In 
this thesis, computational fluid dynamic (CFD) modeling was utilized to simulate fluid and particle 
flow through various acoustofluidic channel geometries and the results were compared with 
biological delivery experiments to cells. It was found a 1-mm diameter Concentric Spiral channel 
is an optimal design as it maximizes wall shear stress (WSS) and US exposure, as compared to 1-
mm and 2-mm diameter Rectilinear channels. With further refinement of the CFD simulations, 
optimization of channel geometry, flow rate, and US parameters could be enhanced. This 
optimization could enable acoustofluidic sonoporation to be translated into manufacturing of CAR 




TABLE OF CONTENTS 
APPROVAL PAGE ......................................................................................................................... ii 
ACKNOWLEDGEMENTS ............................................................................................................ iii 
ABSTRACT .................................................................................................................................... iv 
LIST OF TABLES .......................................................................................................................... vi 
LIST OF FIGURES ....................................................................................................................... vii 
I. INTRODUCTION ............................................................................................................... 1 
Objective ............................................................................................................................. 1 
CAR T-Cell Therapy .......................................................................................................... 1 
Transfection and Transduction ........................................................................................... 3 
Acoustofluidic Sonoporation .............................................................................................. 5 
II. METHODS .......................................................................................................................... 7 
SOLIDWORKS Modeling .................................................................................................. 7 
ANSYS Workbench Setup and Meshing ............................................................................ 8 
ANSYS Fluent Analysis ................................................................................................... 10 
Jurkat T-Cell Culturing, Transfection, and Analysis ........................................................ 15 
III. RESULTS/DISCUSSION .................................................................................................. 18 
ANSYS Computational Fluid Dynamics (“CFD”) Output ............................................... 18 
Jurkat T-Cell Transfection Experiments ........................................................................... 32 
IV. CONCLUSIONS................................................................................................................ 37 
V. RECOMMENDATIONS ................................................................................................... 42 
REFERENCES .............................................................................................................................. 45 






LIST OF TABLES 
Page 
Table 1. Description of transformation methods. ............................................................... 3 
Table 2. Drawbacks of transformation techniques. ............................................................ 4 
Table 3. Reynolds number calculations at inlet velocity = 0.002 m/s. ............................. 11 
Table 4. Reynolds number calculations at inlet velocity = 0.01 m/s. ............................... 11 
Table 5. Selected characteristics for each channel at the optimal mesh size. ................... 15 
Table 6. Volume average WSS values at each inlet velocity ........................................... 19 
Table 7. Volume average WSS values at each inlet pressure. .......................................... 20 
Table 8. Volume average velocity values at each inlet velocity ....................................... 24 
Table 9. Volume average velocity values at each inlet pressure ...................................... 25 
Table 10. Minimum and maximum microbubble velocity values. ................................... 27 
Table 11. Microbubble residence time histogram metrics ................................................ 30 
Table 12. Biologic delivery results for the first cell experiment ...................................... 32 
Table 13. Cell viability results for the first cell experiment ............................................. 32 
Table 14. Biologic delivery results for the second cell experiment .................................. 34 





LIST OF FIGURES 
Page 
Figure 1. Graphical depiction of the CAR T-cell process .................................................. 2 
Figure 2. Renderings of the channels in SOLIDWORKS .................................................. 7 
Figure 3. Labeled named selections (inlet,outlet, fluid flow) ............................................. 8 
Figure 4. Schematic regions labeled where the Reynolds number was calculated ........... 10 
Figure 5. Mesh independence analyses for all the channel geometries ............................ 14 
Figure 6. Image of acoustofluidic sonoporation setup for cell experiments ..................... 16 
Figure 7. Scaled WSS contours for each channel geometry ............................................. 18 
Figure 8. Comparison of WSS for each channel geometry at two inlet velocities ........... 19 
Figure 9. Comparison of WSS for each channel at both inlet pressures........................... 20 
Figure 10. Scatterplot of inlet velocity effect on WSS for each channel .......................... 21 
Figure 11. DPM Concentration contours for each of the channel geometries .................. 22 
Figure 12. Scaled velocity pathline contours for each channel geometry ........................ 23 
Figure 13. Comparison of average velocity for each channel at two inlet velocities ....... 24 
Figure 14. Comparison of average velocity for each channel at both inlet pressures ...... 25 
Figure 15. Scaled microbubble (MB) velocity contours for each channel geometry ....... 26 
Figure 16. Comparison of min/max microbubble velocity for each channel geometry ... 27 
Figure 17. Images of the particle distribution at the outlet of each channel ..................... 29 
Figure 18. Scaled contours of microbubble residence time for each channel geometry .. 29 
Figure 19. Histograms of particle residence time for each channel .................................. 30 




Figure 21. Calcein fluorescence and percent viability for the first cell experiment ......... 32 
Figure 22. Calcein fluoroscence and percent viability for the second cell experiment .... 33 
Figure 23. Association of WSS and calcein fluorescence ................................................ 35 







 The objective of this thesis is to analyze the fluid flow in acoustofluidic channels to 
understand the fluidic forces acting on cells during sonoporation procedures.  
CAR T-Cell Therapy 
 Cancer is caused by unregulated cell growth and inability of the immune system to remove 
these cells. Standard cancer treatments include chemotherapy, radiation therapy, and surgery. 
However, each of these treatments can take a significant physical and mental toll on the patient, 
usually require repeated/regular treatment, and are rarely 100% effective. Current cancer treatments 
can drastically affect a patient’s quality of life and therefore a new treatment modality is needed.  
 Chimeric antigen receptor (CAR) T-cell therapy is a newer, and very promising, cancer 
treatment. There are several FDA approved CAR T-cell treatments currently, with several others 
being explored. Three current, CAR T-cell therapies are discussed briefly below:  
1) Tecartus (brexucabtagene autoleucel) - utilizes a gammaretrovirus vector to modify T-
cells to bind and kill relapsed or refractory mantle cell lymphoma [3] 
2) Kymriah (tisagenlecleucel) - utilizes a lentiviral vector to modify T-cells to recognize 
relapsed or refractory diffuse large B-cell lymphoma and relapsed or refractory acute 
lymphoblastic leukemia [1] 
3) Yescarta (axicabtagene ciloleucel) - utilizes a retroviral vector to alter T-cells to target 
diffuse large B-cell lymphoma (DLBCL), primary mediastinal B-cell lymphoma, and 
high-grade B-cell lymphoma selectively [2] 
All of these therapies have shown a marked effectiveness in patients. During clinical trials, 
Yescarta had 82% of patients respond to the treatment, with 54% reaching complete remission. 
Follow-up data determined that 40% of those reaching complete cancer remission remained in 




respond to treatment, with 40% reaching complete remission; no follow-up data was provided [21]. 
Finally, Tecartus saw very similar results as Yescarta: 87% of patients responded to the treatment 
with 62% reaching complete remission [28]. From this data, it appears that CAR T-cell therapy, or 
more generally, tuning of the adaptive immune response, can be an extremely effective treatment.  
CAR T-cell therapy is effective because it harnesses the patient’s own immune system, 
making use of their T-cells. To begin, a patient’s T-cells are harvested and then genetically 
altered/modified to express a specific antigen receptor. After reprogramming, the T-cells are 
expanded in-vitro, reinfused into the patient, and then can specifically and selectively target and 
kill any cell expressing that antigen through the cell-mediated branch of the adaptive immune 
system. CAR T-cell therapy offers a specificity and sensitivity that chemo, radiation, or surgery 
cannot match. Additionally, the body learns to synthesize T-cells with the specific antigen receptor, 
which builds an active, permanent “immunity” that can reduce or remove the need for repeated 
treatment. The process of CAR T-cell therapy is detailed in Figure 1.   
 
Figure 1. Graphical depiction of the CAR T-cell process from harvesting, transformation, expansion, 
and reinfusion [7]. Once reinfused, the T-cells recognize specific antigens on tumor cells to either 
directly kill the cell or activate other immune cells to clear the tumor.   
 
It is critical to note that all current FDA approved CAR T-cell treatments rely on viral 




for transformation and while the advantages are apparent (no other approved treatment utilizes a 
different method) there are significant disadvantages associated with viral transduction. More on 
various methods of transformation are discussed below.  
Transfection and Transduction 
Transfection and transduction are processes in which exogenous DNA or RNA are 
introduced into a cell to alter gene expression and produce recombinant proteins. Transduction 
specifically relies upon viral vectors to infect cells which can or cannot integrate with the host 
genome while transfection relies upon non-viral methods such as electroporation, microinjection, 
cell squeezing, and sonoporation. Descriptions of each technique are provided in Table 1. 





A specific DNA or RNA sequence is packaged into a viral particle 
(virion) that “infects” cells, through endocytosis of the nucleic acid, 
which is then transported to the nucleus and expressed. The virion 
cannot replicate and is termed “replication-deficient”. The two most 
common methods are via: 
1) An adenovirus which utilizes double stranded DNA (dsDNA) 
that is not integrated into the host genome. 
2) A lentivirus makes use of RNA that is reverse transcribed into 
DNA that is integrated into the host genome.  
Electroporation 
An electrical field is applied to cells through an electroporator that 
contacts aluminum electrodes on each side of a cuvette containing the 
cell suspension. Voltage, typically in the range of 1.0-1.5 kV, is applied 
for a few microseconds up to a millisecond. This disturbs the cell 
membrane and creates transient pores. The potential created can allow 
charged molecules, such as DNA, to be driven through the pores [25].  
Microinjection 
A glass micropipette (typically 0.1-0.5 µm), containing a DNA/RNA 
suspension, is inserted into the cell membrane and/or nucleus. This 
process is typically performed with an inverted microscope under 200x 
magnification. Once injected, the transgene integrates randomly with the 
host genome.  
Cell Squeezing 
Relies on microfluidic channels that are 30-80% smaller than a cells 
diameter. The WSS forces the cell membrane to rearrange creating 
transient pores in the membrane. The biologic can then passively diffuse 
through cell membrane and exert its effect.  
Shear stresses ranging from 400-5000 dyne/cm2 can be created, with 
uptake peaking and only about 20% loss of viability at approximately 





Inert gas microbubbles (MBs) are either oscillated or ruptured via 
ultrasound near cell membranes creating microstreams and/or microjets 
of fluid that increase the fluid shear stress. Like cell squeezing, the shear 
stress creates transient pores in the cell membrane that increase 
permeability [13]. A unique benefit of this technique is that while the 
pores may seal rapidly, the increase in permeability lasts significantly 
longer, up to 12 minutes [14] due to increases in endocytosis.  
 
While some have seen approved clinical applications, such as the CAR T-cell cancer 
treatments detailed previously, each technique is plagued by challenges including, but not limited 
to, limited efficiency and consistency, for different reasons. Drawbacks of each technique are 
detailed in Table 2.  





• Virion size caps size of genetic material that can be introduced 
• Gene can be randomly inserted – may lead to insertion 
mutagenesis [16]  
• Can be difficult to manufacture – classified as Biosafety Level 2 
• Can induce an immune system response [27] 
Electroporation 
• Large voltage pulses can cause significant cell death - requires 
larger number of cells [22] 
• Optimization is not “one-size-fits-all” – requires individual 
optimization for different cell types (voltage, capacitance, etc.) 
• Microscale setups – throughput [16] 
• Macroscale setups – efficiency [16] 
• Shown to cause significant dysfunctions in primary T-cell lineages 
[11] 
Microinjection 
• Requires more complex equipment – microscope, 
micromanipulators, micropipettes, etc.  
• Difficult to scale up to treat large numbers of cells [4] – throughput 
Cell Squeezing 
• Small channels can clog easily  
• DNA/RNA introduction is entirely passive (no driving force) – 
efficiency 
• Consistency of channel dimensions/geometry depending on 
manufacturing method (ex. PDMS lithography) 
Sonoporation 
• Microscale setups – throughput 
• Lower transformation efficiency compared to viral transduction [16] 
• Newer - optimization necessary 
• Acoustic waves affected by size and material of container – alters 






 Acoustofluidic sonoporation is a process in which cells, biologic(s), and microbubbles are 
passed through channels while ultrasound (US) is applied. This process has shown to significantly 
improve molecular delivery compared to bulk sonoporation alone. Previously, microfluidic 
channels (ex. 500 x 200 µm) were utilized, however the PDMS lithography production method 
resulted in significant geometrical inconsistencies between various channels. Newer iterations 
utilize 3D stereolithography (SLA) printing for increased control over channel dimensions, 
however, this has limited the minimum size of the channels to 1 mm x 1 mm. Experimentation has 
shown that the larger channels can result in significant delivery of biologics and greater consistency 
as compared to the previous microfluidic channels. New research has demonstrated that the 
acoustic pressure generated by the ultrasound (US) application creates a pressure gradient within 
the fluidic channels that forces cells and biologics towards the opposite wall of the channel [5], 
thereby combining the effects of cell squeezing and sonoporation. With this movement, larger 
channels (of the mm scale) may be able to achieve similar shear stresses and flow characteristics 
as microfluidic (of the µm scale) channels.  
 While the research and experimentation suggest the acoustofluidic sonoporation is 
effective in delivering biologics, there is lack of understanding of the physical forces that create 
differences in delivery between different channel geometries, namely size and shape. Cells are 
exposed to multiple types of stress, wall shear stress (WSS), fluid shear stress, and microbubble 
rupture shear stress, each of which have been shown to permeabilize cells. While studies have 
explored the shear stress components separately, the interactions of the various components have 
not been evaluated. There likely exists some relationship/correlation between the WSS and 
US/acoustic pressure, due to the movement of particles towards the opposite wall of application. 
This has significant implications on delivery efficiency and post-processing viability as Warboys 
et al. [29] demonstrated that chronic (extended duration) shear exposure reduces cell permeability 




threshold in shear stress that cells can endure before the membrane cannot be repaired and 
dysfunction and/or death occur. Therefore, channel design is of critical importance in maximizing 
transformation efficacy without significantly compromising cell viability. Analyzing the fluid and 
particle flow in these acoustofluidic channels is necessary to develop the understanding that will 
drive optimization of channel design to maximize transformation efficiency.  
 This thesis aims to begin to fill this gap in understanding of the fluidic forces that particles 
experience during acoustofluidic sonoporation procedures. Outcomes of particular interest are the 
WSS generated by fluid flow, particle velocity and flow pattern(s), and particle residence time. The 
findings should assist with optimizing acoustofluidic sonoporation by developing a thorough 
understanding of the effects of channel design. Optimization is necessary to translate this technique 
of cell transformation into clinical practice, in which cell therapies derived from cell transformation 






 Three channel geometries were constructed in SOLIDWORKS 2019: 
1) 1 mm x 1 mm x 25 mm Rectilinear channel 
2) 2 mm x 2 mm x 25 mm Rectilinear channel 
3) 1 mm x 1 mm Concentric Spiral channel  
Figures of each channel are shown in Figure 2.  
 
 
Figure 2. Renderings of the channels in SOLIDWORKS. Channels are defined by the size and 
pattern of the middle feature.  i) 1 mm Rectilinear ii) 2 mm Rectilinear iii) 1 mm Concentric Spiral. 
Note: This numbering scheme will be utilized throughout. 
 
To create each channel, the sketch of each was drawn on top plane and extruded to the 
appropriate height, 1 mm or 2 mm. A plane was added 5 mm from each of the end faces of channel, 
with the normal pointing away from channel body. A center circle, with diameter of 3.97 mm, was 






be connected to the pump (syringe or peristaltic). To connect the channel feature and inlet/outlet 
body features, a loft was created between the features with tangent faces and the result not being 
merged, which was critical for importing the parts into ANSYS.  
ANSYS Workbench Setup and Meshing 
 A new 2020 ANSYS Academic Research Workbench project was created for each channel 




 The SOLIDWORKS models were imported into Geometry component. Using 
DesignModeler, each feature of the five features were named and Named Selections were defined 
including the inlet, outlet, and walls for each channel as shown in Figure 3. The resulting geometry 
data was transferred to the Meshing component.  
 
Figure 3. Labeling inlet, outlet, and fluid flow direction for each channel as was done in ANSYS 






 Within the ANSYS Meshing component, bonded connections were created between 
successive features (i.e. Inlet_Body bonded to Inlet_Adapter, Inlet_Adapter bonded to Channel, 
Channel bonded to Outlet_Adapter, and Outlet_Adapter bonded to Outlet_Body) to ensure that 
ANSYS Fluent would register the entire channel as one system for flow simulations.   
After creating the connections between the features, the Global Mesh settings were altered 
as follows. The Physics Preference was set to CFD with Fluent specified as the Solver Preference. 
The Element Size was kept at its default setting of 2.3667 mm but was set as an input parameter to 
test different mesh sizes for independence. Within the Sizing options, Adaptive Sizing and Capture 
Proximity were disabled, due to the relatively simple geometry of the channels, while both Mesh 
Defeaturing and Capture Curvature were enabled. All other Sizing settings were retained at the 
default values. To ensure that the mesh would produce accurate, reliable results, default settings 
were used within the Quality menu except for alterations as detailed; the Target Skewness was 
decreased to 0.7, Smoothing was set to medium, and the Mesh Metric reported was skewness with 
the maximum, average, and standard deviation set as output parameters. Alongside the mesh 
independence analysis if any mesh size reported a maximum skewness ≥ 0.9, the mesh size was 
excluded from further analysis. Due to the laminar flow scheme and low velocities to be analyzed, 
boundary/inflation layers were necessary to accurately represent flow near the walls, therefore, the 
following Inflation settings were utilized; Automatic Inflation was used within All Faces in Chosen 
Named Selection, with the selection specified as the walls (defined within DesignModeler 
previously). The method for the inflation was set to Smooth Transition and all settings were 
retained at the default value except for the Maximum Layers was decreased to four (4) and Collision 
Avoidance was changed to stair stepping.  
A sweep method was added to the channel feature for both 1 mm channels and recorded as 
the first meshing step. This ensured the channel feature would be comprised of mostly hexahedral 
cells which have been shown to produce more accurate results with less computational time [20]. By 




interfaces with the Inlet/Outlet_Adapter features, and more generally, the entire channel volume. 
The mesh element size was set as an input parameter to align with the global mesh element size. 
The sweep method was not utilized in the 2 mm Rectilinear channel because of the limited size 
decrease from the Inlet/Outlet_Body to the Channel that prevented larger mesh sizes from being 
used. The face meshes on the inlet and outlet side could not match the volume mesh generated by 
the sweep method.  
 
ANSYS Fluent Analysis 
The mesh generated from the preceding steps was transferred to the Setup of the Fluent 
component. On startup, the following solver options were selected, Double Precision and Parallel 
Processing with sixteen (16) processes (CPU: AMD Ryzen 7 2700X Eight-Core Processor, 4.00 
GHz). Within Fluent, the Energy, Viscous, and Discrete Phase models were enabled for the 
analysis. A laminar flow regime was selected for the fluid flow, as Ward et al. has shown that flow 
at low velocities in these small diameter channels is dominated by viscous forces resulting in low 
Reynolds numbers [30]. To confirm a laminar flow regime, the Reynolds number was calculated at 
four different regions for each channel as shown in Figure 4, with the threshold between laminar 
and turbulent flow set to 2300. 
 
Figure 4. Simplified schematic of the fluidic channels with each region where the Reynolds number 
was calculated. Region 1 represents the inlet, Region 2 the beginning of the channel, Region 3 the end 
of the channel, and Region 4 the outlet.  
 The Reynolds number, Re, was calculated using Equation 1 







where D is the diameter/height of the channel at each region, ρ is the fluid density (997 kg/m3 for 
liquid water), V is the fluid velocity at each region, and µ is the dynamic viscosity (0.00091 N*s/m2 
for liquid water). The velocity, V, at region 2 was calculated using the continuity equation with an 
incompressible liquid as shown in Equation 2 
𝑉1𝐴1 = 𝑉2𝐴2 (2) 
where A is the area of flow. An area-weighted average of velocity magnitude at the outlet surface 
was created and used to compute the velocity at region four (4) for each channel. Reynolds numbers 
were calculated for both Vin = 0.002 and 0.01 m/s with the results shown in Table 3 and 4. 
Table 3. Reynolds number calculations for each region of each channel at inlet velocity = 0.002 m/s. 
No region surpassed the 2300 threshold, supporting the assumption of a laminar flow regime.  
Vin = 0.002 m/s 
 Region 1 Region 2 Region 3 Region 4 
1 mm Rectilinear 8.6991 27.1241 27.1241 8.6802 
2 mm Rectilinear 8.6991 13.5620 13.5620 8.7021 
1 mm Concentric Spiral 8.6991 27.1241 27.1241 9.1929 
 
Table 4. Reynolds number calculations for each region of each channel at inlet velocity = 0.01 m/s. No 
region surpassed the 2300 threshold, supporting the assumption of a laminar flow regime. 
Vin = 0.01 m/s 
 Region 1 Region 2 Region 3 Region 4 
1 mm Rectilinear 43.4955 135.6203 135.6203 43.4922 
2 mm Rectilinear 43.4955 67.8101 67.8101 43.5145 
1 mm Concentric Spiral 43.4955 135.6203 135.6203 44.1079 
 
The discrete phase was set to interact with the continuous phase with the default DPM 
Iteration Interval, Maximum Number of Steps, and Step Length Factor. High-Res Tracking was 
enabled for increased accuracy of discrete phase variables. The Pressure Gradient Force was 
enabled within the Physical Models to account for any potential changes the inclusion of particles 
could have on the flow of the particles. Additional tracking options, including Accuracy Control, 
Track in Absolute Frame, and Linearize Source Terms were enabled. The Tracking Scheme was 




parameters, the Method was set to Hybrid and Use DPM Domain was selected to reduce the 
computational load required.  
One (1) injection was added to the discrete phase analysis. Perfluorobutane (C4F10), which 
comprises the microbubbles used within the sonoporation procedures, was added as an inert particle 
material with the following properties [19]: 
1) Density: 24.6 kg/m3 
2) Specific Heat: 809 J/(kg*K) 
The Injection Type was changed to surface, and the inlet was selected as the release surface. 
A Rosin-Rammler diameter distribution was used with a minimum diameter of 1e-06, a maximum 
diameter of 3e-06 m, and a mean diameter of 2e-06 m. The Spread Parameter and Number of 
Diameters were retained at the default values. The options to Scale Flow Rate by Face Area and 
Inject Using Face Normal Direction were enabled. The Velocity Magnitude was set to the 
“Velocity_Inlet” (discussed later), as the particles are suspended in the injected fluid. An input 
parameter defined as “Microbubble_Flow_Rate” was specified for the Total Flow Rate to allow for 
exploration of particle transport at various concentrations (default value: 1e-20 kg/s). Additionally, 
within the Physical Models options, the Drag Law was kept as spherical and rotation was enabled 
following the Dennis-et-al Rotational Drag Law; however, the Angular Velocity Magnitude was 
set to 0 rad/s to decrease the computational load of each simulation.  
Water-liquid (H2O), with default properties, was added as a fluid material and set for both 
interior cell zones. While phosphate buffered saline (PBS) is the typical fluid that cells are 
suspended in during acoustofluidic sonoporation, its density (1.01 g/mL) is only 1% different and 
its viscosity (0.8882 cP) is only 2.45% from liquid water at 25 °C. Therefore, simulating flow with 
liquid water should only produce negligible differences during calculations. For the inlet boundary, 
two input parameters were created, “Velocity_Inlet” and “Pressure_Inlet”, for the Velocity 




exploration of the fluid dynamics at various flow rates and pressures. The outlet boundary pressure 
was set to 101325 Pa (1 atm) and kept constant.  
Residuals were monitored at the default values except for continuity, which was decreased 
to 1e-05 to ensure solutions reached a steady-state/converged. The following Report Definitions 
were created to analyze the simulation results: 
1. Volume Average of Velocity Magnitude 
2. Max of Velocity Magnitude 
3. Volume Average of Static Pressure 
4. Max of Static Pressure 
5. Volume Average of Wall Shear Stress (WSS) 
6. Area-Weighted Average of Wall Shear Stress (WSS) 
7. Area-Weighted Average of Velocity Magnitude, at the outlet only to calculate the 
Reynolds number of the flow 
The default initialization scheme was utilized (Hybrid for ten (10) iterations). The Time 
Scale Factor was retained at one (1) and the Number of Iterations was increased to eight hundred 
(800) to ensure that solutions would converge to a steady state.  
After initializing the simulation, several graphics were created to visually interpret the 
results including: 
1. A faces-only Mesh, excluding the interior of the channel 
2. A WSS Contour 
3. A static pressure Contour 
4. A velocity magnitude Contour, interior portions only 
5. Pathlines of velocity magnitude, interior portions only 
6. A Particle Track of particle residence time, interior portions only 




8. A Scene of the velocity pathlines in the faces-only mesh (set to 70% transparency) 
9. A Scene of the particle residence time particle tracks in the faces-only mesh (set to 
75% transparency) 
10. A Scene of the particle velocity magnitude particle tracks in the faces-only mesh (set 
to 75% transparency) 
A mesh independence analysis was performed for each channel to determine the optimal 
mesh. Mesh element sizes from 0.2 mm to 3 mm were analyzed for each channel. Results of the 
analyses are shown in Figure 5. It should be noted that 0.2 mm was the smallest mesh element size 
that could be tested due to the limited CPU power of the computer used and the 512,000-cell cap 
imposed by the Academic Research version of ANSYS Fluent.  
 
 
Figure 5. Mesh independence analyses for all the channel geometries. The smallest mesh size tested, 
0.2 mm, produced the maximum volume average velocity and a percent difference was calculated for 
the other mesh sizes. The largest mesh that had an ~1% difference was selected for each channel and 










The statistics for each channel at the selected/optimal mesh are given in Table 5. 


















0.5 7227 18169 0.77631 0.23433 0.12624 0.938% 
2 mm 
Rectilinear 




0.4 13784 30690 0.71346 0.20709 0.12755 0.860% 
 
Jurkat T-Cell Culturing, Transfection, and Analysis 
 Jurkat T-cells were diluted to a concentration of 100,000/mL in 18 mL of supplemented 
RPMI medium which contains RPMI medium, 10% fetal bovine serum, and 2% 
penicillin/streptomycin. The cell solution was divided into 3-mL aliquots. Seven (7) experimental 
groups were determined with three (3) replications per group (n = 3/group): 
1. Group #0: Cells only without calcein 
2. Group #1: No flow, no ultrasound 
3. Group #2: Flow through 1 mm Rectilinear channel without ultrasound  
4. Group #3: Flow through 2 mm Rectilinear channel without ultrasound 
5. Group #4: Flow through 1 mm Rectilinear channel with ultrasound  
6. Group #5: Flow through 2 mm Rectilinear channel with ultrasound  
7. Group #6: Flow through 1 mm Rectilinear channel with ultrasound. Samples were 
passed through the device twice to double the ultrasound exposure time. 
For groups #1-6, 333 µL of 1 mg/ml calcein solution was added to each 3-mL cell sample. 
For groups #2-6, flow was through the specified 3D-printed acoustofluidic device using a peristaltic 
pump at 1.5 mL/min. For groups #4-6, 10 µL/mL of cationic microbubbles, synthesized using the 




using a Verasonics P4-1 transducer placed directly on the device at an output peak negative pressure 
of 3.8 MPa, as shown in Figure 6. 
  
Figure 6. Image of acoustofluidic sonoporation setup with the channel connected at both the inlet and 
outlet and the Verasonics US transducer placed on the device.   
 
After the treatment, all samples were washed 3x using the following protocol:  
1. Centrifuge at 1500 g for 5 min 
2. Aspirate 0.9 mL of supernatant, then add 0.9ml of PBS and resuspend pellet 
3. Centrifuge at 1500 g for 5 min 
4. Aspirate 0.9 mL of supernatant, then add 0.9ml of PBS and resuspend pellet 
5. Centrifuge again at 1500 g for 5 min 
6. Aspirate 0.9 mL of supernatant, then add 250 µL of PBS and resuspend pellet 
A 0.5 mg/mL propidium iodide (PI) solution was prepared and after washing, 5 µL of the 
PI solution was added to each sample producing a final concentration in each sample of 10 µg/mL. 




(Miltenyi Biotec, Auburn, CA, USA) with 10,000 events recorded per sample. Data was analyzed 
using FlowJo (Ashland, OR, USA) to determine green calcein fluorescence (in the B1 “FITC 
channel), which is an indicator of delivery efficiency, and red PI fluorescence (in the B3 “PerCP” 
channel), which is an indicator of cell viability. The data from this experiment was analyzed using 
an analysis of variance (ANOVA) in Minitab 19 with channel, flow condition, US inclusion, and 
number of flow throughs included as factors. The significance level was set to α = 0.05.   
 For a second set of biologic delivery cell experiments, that same procedure described above 
was utilized with the following experimental groups (n = 6/group): 
1. Group #1: Flow through 1 mm Rectilinear channel without ultrasound 
2. Group #2: Flow through 2 mm Rectilinear channel without ultrasound 
3. Group #3: Flow through 1 mm Concentric Spiral channel without ultrasound 
4. Group #4: Flow through 1 mm Rectilinear channel with ultrasound 
5.  Group #5: Flow through 2 mm Rectilinear channel with ultrasound 
6. Group #6: Flow through 1 mm Concentric Spiral channel with ultrasound 
Unlike experiment one above, the data from this second experiment was analyzed using 
student t-test comparisons, with the Bonferroni correction, in Minitab 19. The significance level 
was set to α = 0.05 for all tests.  
These two experiments were completed in order to compare delivery results to the CFD 
outputs to potentially correlate certain variables (e.g. WSS) with differences in delivery. While 
exact causes for variations in delivery cannot be determined without further research, the results 
should suggest areas of optimization, additional variables to explore, and constraints of current 
technology and techniques. This work provides the beginnings of a foundation from which to 
develop greater understanding about the causes of cell permeabilization during acoustofluidic 






ANSYS Computational Fluid Dynamics (“CFD”) Output 
 The first outcome of interest was wall shear stress (WSS), as this is one of the most critical 
factors in cell transformation/biologic delivery. WSS contours were created for each channel and 
scaled to a common range; the minimum value was set to 2.32e-03 Pa and the maximum value was 
set to 3.29e-01 Pa. The results for each channel are shown in Figure 7.  
 
Figure 7. Scaled WSS contours for each channel geometry. In all channels, the maximum occurs 
within Channel feature, with the 1 mm Concentric Spiral producing the maximum value. Due to the 
maximum scale value being based on the 1 mm Concentric Spiral, differences in the 2 mm 
Rectilinear channel are not easily distinguishable.  
  
As shown in Figure 7, the 1 mm Concentric Spiral channel produces greater WSS 
throughout the channel, with peak values occurring near the center of the channel at the inner edges 
of the 180° turn. However, in the 1 mm and 2 mm Rectilinear channels, the peak WSS occurs where 
the lofted section from the inlet and outlet joins with the channel. To compare the WSS generated 
by each channel, the volume average WSS output parameter was investigated for each channel 
geometry and the minimum and maximum inlet velocity values, the results are shown in Figure 8 







Figure 8. Comparison of volume average WSS for each channel geometry at two different inlet 
velocities (Vin) – 0.002 and 0.01 m/s. In both cases, the 1 mm Concentric Spiral channel produced the 
greatest value while the 2 mm Rectilinear channel produced the smallest.   
 
Table 6. Volume average WSS values at each inlet velocity.  
Channel 
Vin = 0.002 m/s Vin = 0.01 m/s 
WSS Vol Avg. (Pa) WSS Vol Avg. (Pa) 
1 mm Rectilinear 0.01151 0.05808 
2 mm Rectilinear 0.00110 0.00554 
1 mm Concentric Spiral 0.03183 0.16574 
 
The WSS output parameter calculations support the results demonstrated within the WSS 
contours, with the 1 mm Concentric Spiral channel producing the maximum WSS. This is likely 
caused by the fact fluid at the inner edge of each curve/turn flows faster than fluid at the outer edge. 
The regional increase in flow rate proportionately increases the WSS. It should be noted that when 
the inlet velocity is set to 0.002 m/s, the 1 mm Rectilinear channel is 946.36% greater than the 2 
mm Rectilinear channel and the 1 mm Concentric Spiral channel is 176.54% greater than the 1 mm 
Rectilinear. This same trend exists when the inlet velocity is increased by 5x, however, the percent 




increase) and between the 1 mm Concentric Spiral and 1 mm Rectilinear to 185.37% (a 8.83% 
increase).  
Additionally, the WSS was investigated at two different inlet pressures, 1 and 2 atm, with 
results shown in Figure 9 and Table 7.  
 
Figure 9. Comparison of volume average WSS output for each channel at both inlet pressure = 1 and 
2 atm. For all three geometries, there is a negligible (< 1%) difference between the calculated values. 
This demonstrates that fluid pressure likely does not have a significant effect WSS particles 
experience.  
 





Analysis of the WSS measurements in Table 7 highlights that there is nearly no difference 
in WSS values when the inlet pressure is increased. This is likely due to how WSS, τ, is calculated 





where µ is dynamic viscosity, Q is the flow rate, W is the width of the channel, and h is the height 
of the channel. Pressure is not one of the variables, nor influences any of the variables as µ is 
Channel 
Pin = 1 atm Pin = 2 atm 
WSS Vol Avg. (Pa) WSS Vol Avg. (Pa) 
1 mm Rectilinear 0.01151 0.01151 
2 mm Rectilinear 0.00110 0.00110 




characteristic of the fluid which is assumed to be incompressible and therefore constant, Q is 
constant value set on the pump (syringe or peristaltic), and W and h are the geometric dimensions 
of the channel.  
Further analysis of the WSS at each inlet velocity tested demonstrates a unique trend for 
each geometry, as shown in Figure 10. As the inlet velocity value increases, the difference in WSS 
generated by each channel diverges by greater amounts. A possible explanation for this is the 
location in which particles flow through each geometry, which is discussed in more detail later. 
Briefly, in the Rectilinear channels, particles seem more distributed throughout the channel volume 
but in the spiral channel, particles tend to concentrate near the turns. As mentioned previously, 
higher flow rates at the inner edge of each curve/turn increases WSS, as highlighted in Equation 3. 
Additionally, this is likely influenced by the flow regime becoming less laminar with ever-
increasing fluid velocity that results in swirling/mixing, which should produce more interaction 
with the walls of the channel.  
 
Figure 10. Comparison of WSS generated in each channel geometry at various inlet velocities. A 
unique trend exists in that as the inlet velocity increases, the difference in WSS generated by each 
channel increases. This difference could be critical in optimizing channel geometry to maximize 
biologic delivery and minimize decrease in cell viability for acoustofluidic sonoporation procedures.  
 
It is important to consider the proportion of particles that are experiencing WSS, as not 
every particle can flow fully along the walls of each channel. Jurkat T-cells typically have a 




cells could physically fit across the width of the channel. Only those immediately adjacent to the 
wall will experience significant WSS, which may influence biologic delivery/cell transformation. 
A DPM Concentration contour was created on the mid-plane in the Z axis to analyze the spread of 
particles in each channel to see a relative distribution of particles that likely experience high WSS 
values. These results illustrate that particle concentrations may not be uniform between the different 
sides of the Concentric Spiral geometry, as compared to both Rectilinear geometries. It should be 
noted that the particles analyzed here were the perfluorobutane microbubbles and not specifically 
cells, but these results provide some insight into particle movement and distribution throughout 
each geometry given the expected interactions between cells and microbubbles during 
acoustofluidic sonoporation procedures. The contours, specifically focused on the Channel feature, 




Figure 11. DPM Concentration contours for each of the channel geometries analyzed. In both 
Rectilinear channels, the spread is fairly uniform throughout the area. In the 2 mm Rectilinear 
channel, there does appear to be a slightly higher concentration of particles near the walls. In the 1 
mm Concentric Spiral, the distribution of particles is not uniform. A higher concentration tends to 
exist near the walls after the inlet and continuing until after the 180° turn, which may suggest that a 
greater percentage of particles are experiencing a higher WSS in this channel compared to the 
Rectilinear geometries.  






To explore how fluid flows through each channel, a pathlines graphic was created of the 
velocity magnitude for each channel and scaled to a common range; the minimum value was set to 
0 m/s and the maximum value was set to 3.77e-02 m/s. The results for each channel are shown in 
Figure 12. 
 
Figure 12. Scaled velocity pathline contours for each channel geometry. For the 1 mm Rectilinear 
channel, the peak occurs at the connection between the channel and outlet loft, whereas in the 1 mm 
Concentric Spiral, the peak occurs after the first curve and continues until the outlet loft.  
 
As shown in Figure 12, the 1 mm Concentric Spiral channel produces greater velocity 
throughout the channel, with the peak value(s) occurring following the first turn and continuing 
until the channel connects to the loft. In the 1 mm Rectilinear channel, the peak velocity occurs 
where the lofted section from the inlet and outlet joins with the channel. This is explained through 
the continuity equation which states that to maintain a constant flow rate in a smaller area, the 
velocity must increase when the fluid is incompressible. The agreement between established 
defining fluid dynamic equations and characteristics with the CFD output supports the validity of 
these results. To quantitatively compare the velocity profiles of each channel, the volume average 
velocity magnitude output was investigated at both the minimum and maximum inlet velocity 







Figure 13. Comparison of volume average velocity output for each channel at both Vin = 0.002 and 
0.01 m/s. Similar to the WSS values highlighted in Figure 8, the 1 mm Concentric Spiral generates 
the greatest value, and the values diverge by greater amounts as Vin increases.  
 
Table 8. Volume average velocity values at different inlet velocity values 
Channel 
Vin = 0.002 m/s Vin = 0.01 m/s 
Velocity Avg. (m/s) Velocity Avg. (m/s) 
1 mm Rectilinear 0.00501 0.02549 
2 mm Rectilinear 0.00351 0.01757 
1 mm Concentric Spiral 0.00828 0.04329 
  
As shown within Table 8, a 5x increase in inlet velocity resulted in an approximately 5x 
increase in resultant average velocity. Similar to the WSS trend shown in Figure 8, as the inlet 
velocity increases, the separation in average velocity increases. At Vin = 0.002 m/s, the percent 
difference between the 1 mm Rectilinear Channel and 1 mm Concentric Spiral is 65.27% versus at 
Vin = 0.01 m/s, the percent difference is 69.83% (a 4.56% increase). Between the 1- and 2-mm 
Rectilinear channels, the difference increases by 2.34 %, from 42.73% at Vin = 0.002 m/s to 
45.08% at Vin = 0.01 m/s. Combining the results for both WSS and average velocity, a pattern 




fluid dynamics than in the 1 mm and 2 mm Rectilinear channels. It is important to note that the 
viscosity, flow rate, and geometric dimensions are the same for the 1 mm Rectilinear and 1 mm 
Concentric Spiral channels, and yet, there is an appreciable difference in the flow properties. This 
suggests that difference is affected by the way in which fluid moves through each channel, for 
example, directly flow to the center versus the walls. Due to this impact, there should be greater 
delivery/transformation within the 1 mm Concentric Spiral channel versus the Rectilinear channels, 
which is supported by the Jurkat T-cell experiments discussed later.  
Additionally, the average velocity was investigated at two different inlet pressures, 1 and 
2 atm, with the inlet velocity held constant. Results are shown in Figure 14 and Table 9. 
 
Figure 14. Comparison of volume average velocity output for each channel at both inlet pressure = 1 
and 2 atm. Velocity follows the same trend as WSS, there is a negligible (< 1%) difference with 
increasing pressure, demonstrating that fluid pressure likely does not have a significant effect on the 
fluid dynamics. 
 
Table 9. Volume average velocity values for each channel geometry at both Pin = 1 and 2 atm.  
Channel 
Pin = 1 atm Pin = 2 atm 
Velocity Avg. (m/s) Velocity Avg. (m/s) 
1 mm Rectilinear 0.005014 0.005014 
2 mm Rectilinear 0.003511 0.003511 





Similar to how inlet pressure had a negligible effect on WSS, there is almost no difference 
in average velocity with a 1 atm increase in inlet pressure. Only small (< 1%) differences exist and 
are not detailed due to rounding of output values. Therefore, changes in the pressure will not be 
investigated in succeeding analyses of discrete phase particles.  
 The key outcome of interest in acoustofluidic sonoporation procedures is biologic 
delivery/cell transformation efficacy. This is affected by particle velocity/flow rate, which 
determines the WSS cells experience, and particle residence time, which determines the amount of 
US exposure. It should be noted that the particles examined in the Fluent analyses were 
representative of the microbubbles, not T-cells, due to the difficulty of accurately modeling T-cell 
properties. Contours of particle velocity were created for each channel geometry and were rescaled 
to a common range of 4.81e-04 m/s to 4.18e-02 m/s. The resulting contours are shown in Figure 15, 
with quantitative comparison of the minimum and maximum values highlighted in Figure 16 and 
Table 10.   
  
 
Figure 15. Scaled microbubble (MB) velocity contours for each channel geometry. The 1 mm 
channels (Rectilinear and Concentric Spiral) generate very similar values, apart from the inner 180° 
turn and final curve in the Concentric Spiral. This points to how both the channel size and geometry 







Figure 16. Comparison of minimum and maximum microbubble velocity values for each channel 
geometry at both Vin = 0.002 and 0.01 m/s. The same trend detailed for both WSS and velocity is 
seen with particle velocity.  
 
Table 10. Minimum and maximum microbubble velocity values for each channel and two different 
inlet velocities.  
  
In Table 10, the minimum microbubble velocity at both inlet velocities is very similar 
between the channels and occurs at the Inlet/Outlet_Body features, demonstrating that input 
conditions are similar which supports the validity of the CFD output. Like the other outputs 
previously considered, a 5x increase in inlet velocity results in an approximately 5x increase in 
maximum microbubble velocity. However, the trend about increasing separation between the 
different geometries does not entirely hold for microbubble velocity. At Vin = 0.002 m/s, the 
percent difference between the 1 mm and 2 mm Rectilinear channels is 140.34%, but at Vin = 0.01 
Channel 
Vin = 0.002 m/s Vin = 0.01 m/s 
Min MB Velocity 
(m/s) 
Max MB Velocity 
(m/s) 
Min MB Velocity 
(m/s) 
Max MB Velocity 
(m/s) 
1 mm Rectilinear 0.0004 0.0286 0.0033 0.1253 
2 mm Rectilinear 0.0005 0.0119 0.0023 0.0578 
1 mm Concentric 
Spiral 




m/s, this difference decreases to 116.78%. While it is unlikely that the 2 mm Rectilinear channel 
could attain a similar value as the 1 mm Rectilinear channel when Vin is kept constant, this trend 
could be beneficial in clinical application. The 2 mm Rectilinear channel can likely support a 
greater flow rate for more time, which could result increase transformation efficiency per unit time 
(aka more cells transformed in the same time frame). The additional increase in flow rate could 
potentially create a similar particle velocity as the 1 mm channel geometries. While the gap in 
particle velocity closes between the Rectilinear channels, the previous trend of increased separation 
holds for the 1 mm Rectilinear and 1 mm Concentric Spiral geometries, which increases from a 
percent difference of 46.15% at Vin = 0.002 m/s to 60.42% at Vin = 0.01 m/s. As seen in Figure 
14.iii, the peak particle velocity occurs at the center 180° turn, with increased values occurring 
again at the last curve just prior to the outlet. Other interesting phenomena that can be seen in these 
results is the spread of particles at the outlet of each channel. In the 1 mm Rectilinear channel, 
particles nearly fill the volume of the Outlet_Body feature. In the 2 mm Rectilinear channel, 
particles fill the entire volume, likely due to the limited decrease in channel diameter/height 
between the inlet and channel. However, in the 1 mm Concentric Spiral geometry, the particles stay 
fairly condensed in the center of the outlet. While it is unlikely these flow patterns influence cell 
transformation/biologic delivery, this information could be beneficial in designing channels to 
direct particles in a specific direction. Likely, particle density could influence the movement, which 
could be adapted to serve as a sorting mechanism for collecting transformed cells, untransformed 
cells, and unruptured microbubbles, assuming a large enough variation in density. The spread of 





Figure 17. Images of the particle distribution at the outlet of each channel. The solid black line 
denotes the outer wall of the outlet while the dashed black line denotes the area in which particles are 
contained. Even though velocity values are similar for each channel, a unique spread is generated. 
 i) 1 mm Rectilinear ii) 2 mm Rectilinear iii) 1 mm Concentric Spiral 
  
 Particle residence time was also compared between the channels at Vin = 0.002 m/s, with 
a common scale of 0 s to 5.09e01 s. Contours of particle residence time are shown in Figure 18 
while quantitative comparisons are presented in Figure 19 with histograms of the distribution of 
residence time and Table 11 which contains general statistics (min, max, mean, and standard 
deviation) for each distribution.  
 
Figure 18. Scaled contours of microbubble residence time for each channel geometry. Several unique 
trends are revealed such as a difference between the inner and outer wall of the 1 mm Concentric 
Spiral (likely correlated to particle velocity) and a difference between the core of the flow and the 










Figure 19. Histograms of particle residence time for each channel. These reveal a slight bimodal 
distribution for each channel; the majority of particles exit quickly, however, anywhere between 10-
15% exit in significantly longer times. It is important to note that these potential outliers could skew 
metrics such as the mean.  
 
Table 11. Key metrics for each channel’s microbubble residence time histogram.  
 
 
The particle residence time results reveal that the 1 mm Rectilinear and 1 mm Concentric 
Spiral channels share a very similar residence time spread, despite having vastly different particle 
velocities. There is only a 10.36% difference in the mean residence time at Vin = 0.002 m/s, yet a 
46.15% difference in max velocity. This has important considerations as the 1 mm Concentric 
Spiral channel is longer than the 1 mm Rectilinear channel, yet particles move through each in the 
same time. This implies that particles spend a greater amount of time within the US field, due to 
increased overlap with the ultrasound transducer, and experience greater shear stress in the 1 mm 
Concentric Spiral channel, which should result in greater biologic delivery.  
 Residence Time (s) 
 1 mm Rectilinear 2 mm Rectilinear 1 mm Concentric Spiral 
Mean 9.08999 16.6448 10.0313 
Standard Deviation 3.16481 11.1707 3.17839 
Min 5.54721 7.2262 6.93633 






Additionally, the core of each channel has the lowest residence time, which is comparable 
between all the channel geometries; the differences arise when particles begin to spread to the outer 
edge of the outlet. While there is a maximum of 50.9 s, with ~10% of particles having a residence 
time > 30 s, based on the histogram in Figure 18.ii, 45% of the particles in the 2 mm Rectilinear 
channel exit in < 12.50 s. This variation is explained by analyzing the microbubble velocity 
distribution at the outlet in unscaled images of the different geometries, as shown in Figure 20. 
Compared to the 1 mm channel geometries, there is a velocity difference between the core/center 
of the flow and outer edge in the 2 mm Rectilinear channel. Using relative values for the velocity, 
the center is approximately 3.90e-03 m/s versus the outer edge at 4.81e-04 m/s, a 710.81% difference. 
This significant difference results in a wider range for particle residence time, as compared to the 
other geometries.  
 
Figure 20. Unscaled images of microbubble velocity, focused on the outlet, for each channel. In both 
1 mm configurations, there is little to no difference in the particle velocity throughout the outlet. 
However, in the 2 mm Rectilinear channel, a distinct difference can be seen from the center to the 







Jurkat T-Cell Transfection Experiments 
Results of the first set of Jurkat T-cell biologic delivery experiments are shown in Figure 
21 and Table 12 and 13.  
 
 
Figure 21. i) Relative calcein fluorescence between the difference experimental groups (n = 3) for the 
first set of transformation experiments. An ANOVA analysis revealed that US is the only significant 
factor in altering calcein delivery (p < 0.001) ii) Percent viability (1 – PI intensity) for each 
experimental group. An ANOVA analysis revealed that the inclusion of US significantly reduced 
viability (p < 0.001), however, all viabilities remained > 75%.   
 
Table 12. Relative (to No Flow condition) calcein fluorescence mean and standard deviation for the 
six experimental groups. 














Fluorescence (xNo Flow) 
1.0000 0.9612 0.9947 3.1873 3.4340 4.0250 
Standard Deviation of 
Calcein Fluorescence 
0.1575 0.2024 0.2307 0.5888 0.7900 1.4355 
 
Table 13. Cell viability mean and standard deviation for the seven experimental groups. 
   Flow Only US Treatment 






















 Analysis of the relative calcein fluorescence in Figure 21.i highlights that while there may 
be a nearly 10x increase in volume average WSS (0.01151 Pa vs. 0.00110 Pa) between the 1 mm 
and 2 mm Rectilinear channels, there is no significant difference in calcein delivery. Even with the 
addition of US, whose effect should be relative to the residence time, there is no significant 
difference. The seventh group (US+MB+1mm Device, 2X TX) was used to address for the nearly 
2x difference in mean particle residence time between the channels and still did not result in a 
significant change in delivery. These results suggest that WSS has a negligible effect on delivery 
efficacy in these acoustofluidic channels, the main determinant is the inclusion of US. While 
literature has shown that flow alone in microfluidic channels can result in significant cell 
transformation [23, 24], in the larger fluidic channels, the WSS can likely not reach the necessary 
threshold to permeabilize cells.  
 The second biologic delivery experiments were performed to compare calcein delivery and 
cell viability between all three channel geometries. Graphical comparisons of relative calcein 
fluorescence and cell viability are shown in Figure 22, with the values given in Table 14 and 15.  
 
Figure 22. i) Comparison of the channel geometries with and without ultrasound treatment (n = 
6/group). Ultrasound treatment significantly enhanced calcein delivery to Jurkat T-cells in each 
device (p < 0.001). Ultrasound treatment enhanced calcein delivery to Jurkat T-cells in the 1 mm 
Concentric Spiral channel compared to both the 1 mm and 2 mm Rectilinear channels (p < 0.001). ii) 
Ultrasound treatment reduced cell viability (1 – PI intensity) in fluidic devices (p < 0.001), however, 







Table 14. Relative (to 1 mm Rectilinear, Flow Only) calcein fluorescence mean and standard 
deviation for the six experimental groups. 
 Flow Only US Treatment 












Average Calcein Fluorescence 
(x1mm Rectilinear Flow Only) 
1.0000 1.0443 0.3781 3.3321 3.6111 9.3617 
Standard Deviation of Calcein 
Fluorescence 
0.2394 0.3018 0.1656 0.7605 1.0730 0.2056 
 
Table 15. Cell viability mean and standard deviation for the six experimental groups. 
 Flow Only US Treatment 












Average Cell Viability (%) 89.28 88.85 94.14 81.63 79.85 78.43 
Standard Deviation of Cell 
Viability 
1.43 1.83 2.25 4.78 10.19 0.45 
 
 Figure 22.i supports the results demonstrated in the first set of cell experiments, flow alone 
does not produce a significant increase in calcein delivery and even large differences in WSS 
between the different geometries does not create appreciable differences. An interesting aspect to 
note about these results is that the 1 mm Concentric Spiral channel had a reduced relative 
fluorescence compared to both Rectilinear channels in the flow only condition, despite having the 
greatest volume average WSS; this trend is reversed however once US is added, likely due to the 
increased US exposure. Additionally, the conclusion that US is the main determinant in delivery is 
supported be the figure, as the inclusion of US increases the relative fluorescence by at least 3-fold 
in all the channels. The significant (p < 0.001) difference between the Rectilinear channels and the 
Concentric Spiral channel is likely driven by the increased US exposure due to the increased length 
of the Concentric Spiral channel. As discussed previously, while residence time is comparable 
between both 1 mm configurations, the increased length and increased overlap of the ultrasound 
transducer in the Concentric Spiral geometry creates a greater opportunity for microbubble rupture 
and cell permeabilization. It should be noted that even with a 9x increase in relative fluorescence, 




 To explore potential connections between the CFD simulation results and cell experiment 
results from experiment 2, Figure 23 displays the percent difference in average WSS and relative 
calcein fluorescence between the 1 mm and 2 mm Rectilinear channels (left) and between the 1 
mm Rectilinear and 1 mm Concentric Spiral channels (right).  
 
Figure 23. Comparison of average WSS and Relative Calcein Fluorescence between the channel 
geometries. While a 946% difference exists between the 1- and 2-mm Rectilinear channels, there is a 
slightly decreased fluorescence in the 1 mm diameter channel compared to the 2 mm diameter 
channel. However, there is a smaller difference in average WSS between the 1 mm Rectilinear and 
Concentric Spiral yet there is a significant increase in calcein fluorescence, contrary to the trend 
noted with the Rectilinear geometries. These results suggest that average WSS may not be the main 
determinant in biologic delivery.  
 
As noted previously, while there is a stark difference in the average WSS and velocity 
magnitude between the Rectilinear geometries, there is no significant difference in calcein delivery, 
likely due to minimal overlap with the US transducer. Particles may spend up to 17 s or 51 s in the 
1 mm and 2 mm Rectilinear channels, respectively, but much of this time is in the inlet and outlet 
where no US is applied. On the other hand, the differences in average WSS is smaller between the 
1 mm Rectilinear and Concentric Spiral geometries; but there is a significant difference in calcein 




should be noted that these conclusions are complicated by the fact the CFD simulations assumed 
steady flow (such as from a syringe pump) while the cell experiments were conducted using a 
peristaltic pump; therefore, pulsatile flow could affect these results and complicate the comparison 
of each analysis. Despite this limitation, these results suggest that average WSS may not be the 





Comparing both the CFD and cell experiment results highlights that the 1 mm Concentric 
Spiral channel is currently the optimal channel design for maximizing biologic delivery. However, 
this is likely caused by greater overlap of the US transducer with the channel yielding increased 
US exposure compared to either Rectilinear geometry. Based on the results shown in Figures 21.i 
and 22.i, US is the main determinant in altering biological delivery within the fluidic channels. To 
be more specific, it appears that the 180° turn is the geometry feature that sets the 1 mm Concentric 
Spiral apart from the 1 mm Rectilinear channel. While difficult to see in Figure 7, the 180° turn 
produces the peak volume average WSS value and as shown in Figure 15, similar particle velocities 
are achieved throughout both the 1 mm Rectilinear and 1 mm Concentric Spiral channels except at 
this center turn, and even more revealing, this significant spike in particle velocity does not decrease 
particle residence time. These findings suggest that a series of parallel 180° turns could be an 
effective channel design for increasing the WSS, residence time, and US exposure; an example of 
this proposed channel is shown in Figure 24.  
 
Figure 24. Potential design for channel with multiple 180° turns. The red circle denotes how a 





 Aside from suggesting an optimal geometry, these results demonstrate two other important 
conclusions: 1) inlet pressure has a negligible effect on the fluid dynamics and 2) a flow rate of 1.5 
mL/min (Vin = 0.002 m/s) is not great enough to generate WSS values that significantly alters 
membrane permeability without US exposure. Figures 9 and 14 highlight that fluid pressure does 
not significantly alter the fluid dynamics as the output values only vary by at most 1% when 
increasing Pin from 1 to 2 atm. While not unexpected knowing that the defining equation for WSS 
in a laminar flow regime does not include a variable for pressure, there were no changes to particle 
flow position/pattern with changes in pressure. Figures 21.i and 22.i point to how the WSS can 
likely not reach some threshold value to significantly alter membrane permeability within these 
larger, millimeter sized channels. However, WSS may be important in sensitizing cells to the 
acoustofluidic treatment, which could explain the 9-fold increase in calcein fluorescence seen in 
Figure 22.i. Since all the values in Equation 1 are constant, except for flow rate, Q, only increases 
in flow rate could potentially shift WSS into a range that would result in significant biologic 
delivery.  
 There are a number of limitations and refinements to the present analyses that should be 
addressed in future CFD modeling. In this analysis, the entire channel volume was utilized to 
calculate the output parameters, specific features, regions, sections, etc. could not be investigated 
and compared individually due to the channels being modeled in SOLIDWORKS and imported 
into ANSYS. To address this limitation, the channels should be designed within ANSYS 
DesignModeler so more specificity could be applied in analysis. Seen throughout the analyses 
presented, the main differences present within the Channel feature, however calculated values 
include the inlet/outlet portions. If the channels were built within DesignModeler, the values within 
the Channel could be extracted independently, removing the inlet/outlet artifact, thereby producing 
more accurate results.  
Another limitation in the current work was the inclusion of only one discrete phase model, 




injection is likely representative of the actual microbubbles used, they are likely not representative 
of the Jurkat T-cells which have a larger diameter (5-7 µm), a different density, and may not follow 
all the same laws/dynamics. Therefore, the flow patterns seen likely do not describe Jurkat T-cell 
dynamics accurately. Additionally, the interactions between microbubbles and Jurkat T-cells could 
not be captured in the present simulations. Collisions could represent a significant factor in biologic 
delivery efficiency, as the closer a microbubble is to a cell when it ruptures exponentially increases 
the shear the cell experiences. If there is a different flow pattern for each particle, finding 
geometries that favor mixing/interaction could be the next step in further increasing biologic 
delivery consistency and efficacy.  
Finally, the assumption of a laminar flow regime within the fluidic channels may not be 
applicable. The actual flow regime should be explored through high-speed photography to 
determine what type is present. ANSYS Fluent offers a wide range of turbulence models (ex. 
Spalart-Allmares, k-ε, k-ω, etc.), so it is likely that a model will fit with the actual flow regime. If 
flow is found to not be laminar, the current results are essentially invalid, but do provide a useful 
background. It should be relatively simple to change the Viscous model within each simulation and 
re-do the analyses, thereby producing more valid results.  
 Future work should center around investigating the WSS threshold value that permeabilizes 
cells and produces a significant increase in biologic delivery without US. Alongside calculating the 
value, the duration in which a cell needs to be exposed to this WSS should also be investigated. 
After determining these values, the trends presented in Figure 10 could be utilized to calculate the 
necessary inlet flow rate/velocity that will create the necessary WSS which could then be coupled 
with a channel geometry that exposes them for the necessary duration (e.g. a narrow, short tube to 
maximize WSS for enhanced permeabilization of cells followed by a larger geometry to slow 
particles and increase residence time within the US beam). Currently, it appears that flow is not 
necessary for transformation, and applying US to a static cell suspension in a vial could potentially 




delivery with this approach. However, making use of flow to supplement the US effect would 
increase throughput, biologic delivery consistency, and potentially support acoustofluidic 
sonoporation as becoming a gold-standard for cell transformation and assist its clinical translation. 
Additionally, knowing the needed WSS would aid in channel design optimization.  
Two other refinements to the current models include investigating transient/pulsatile flow, 
as driven by a peristaltic pump, versus steady flow, as driven by a syringe pump. Pulsatile flow 
could alter flow rate creating regions of increased/decreased velocity that would change WSS and 
US exposure and drive discrete particles into specific flow patterns to favor interactions/collisions. 
If changes in flow rate were significant, pulsatile flow could move the entire flow regime from 
laminar to turbulent and vice-versa, which has the potential to create unique flow patterns of 
swirling/mixing. Combined with changing geometry (ex. a smaller followed by a larger diameter), 
this presents the best optimization scheme. Finally, simulating the US effects would greatly 
improve the correlation ability of the CFD calculations to the cell experiment results. ANSYS 
Fluent offers the ability to model acoustics which could address this gap; however, a much more 
in-depth knowledge of the necessary modeling and setup is needed to incorporate acoustics. As 
noted previously, research has shown that acoustic radiation force effects generated by US 
application can alter the position in which particles flow through the channel, which would likely 
change the DPM Concentration contours presented in Figure 11. This movement likely influences 
the flow dynamics and shear stresses that particles experience, especially since this movement is 
typically towards the opposite wall of the transducer which should also increase the proportion of 
particles that experience a significant amount of WSS.  
Taken together, these conclusions highlight that this thesis only began to scratch the surface 
of understanding the fluidic forces within acoustofluidic channels. Geometries that alter the 
direction of flow (e.g. 180° turn) versus straight channels appear to be effective in increasing the 
WSS particles experience, cause a large increase in particle velocity without significantly changing 




be the most significant factor in improving biologic delivery within 1- and 2-mm channels, 
therefore, channel geometry should be tailored to maximize residence time. Future research should 
focus on validity the flow regime in acoustofluidic channels to ensure accuracy of CFD generated 
results and adding additional parameters to the CFD models (e.g. multiple discrete phase models). 
Additional refinement of these models could reveal new details and trends that will be important 





Acoustofluidic sonoporation is a promising alternative for cell transformation, however, 
there is still a significant amount of work needed to fully understand the physical forces and fluid 
dynamics that drive cell permeabilization in the devices. The work presented in this thesis details 
a beginning foundation for which to direct future analyses and experimentation. These analyses 
should be repeated with additional computing power and a non-academic version of ANSYS to test 
mesh element sizes smaller than 0.2 mm. While the mesh independence analyses began to reach 
steady-state values for the various output parameters, further refinement should provide more 
accurate results that will result in a more thorough understanding of the fluid dynamics. 
Additionally, with more computing power, the Jurkat-T-cells and microparticles could be added as 
discrete phase models and interactions, whether DEM or stochastic collisions, could be introduced. 
This information could reveal unique flow patterns for each type of particle; how interactions affect 
velocity, residence time, and other variables; and better correlate CFD calculations to cell 
experiment results. For example, new research is suggesting that the use of cationic microbubbles 
versus neutral microbubbles, results in a “stickiness” to Jurkat T-cells that increases permeability 
and biologic delivery [18]. Building Jurkat T-cells into the ANSYS Fluent analyses and adding a 
“sticky” collision with the microbubbles has the potential to significantly improve acoustofluidic 
sonoporation knowledge. This information would be immensely useful in designing fluidic 
channels that drive particles to interact, maximizing WSS and US exposure, while increasing 
throughput.   
As analyses are refined, more biologic delivery experiments should be conducted. 
Variables other than channel geometry should be investigated such as inlet flow rate/velocity, inlet 
pressure, US exposure time, US pressure, and more. Based on both the CFD output and cell 
experiments, the shear stress generated by flow alone is not enough to permeabilize cells 




be tested to understand if there is a threshold that results in a significant change in biologic delivery, 
which could then be modeled in ANSYS to develop a WSS threshold. If there are significant 
differences in delivery with changes to inlet pressure, the results of this analysis would no longer 
be valid as a laminar flow regime does not accurately capture this effect. This information would 
be extremely beneficial for refining the CFD models. Eventually, with significant agreement 
between the CFD models and cell experiment results, the models could be used for predicting 
delivery and viability results in new channel geometries prior to them being printed and tested. 
Moving forward, to maximize transformation, the 1 mm Concentric Spiral with US should 
be used. Pooling all the results presented suggests that out of the three geometries, it is the optimal 
design currently. The cell suspension should be pumped at the maximum flow rate/velocity 
possible, adjusting as necessary to maintain a cell viability ≥ 75%. If results demonstrate a 
significant decrease in biologic delivery, this is likely caused by a decrease in residence time that 
limits US exposure; multiple channel flow throughs (ex. 2X, 3X) could be used to address this 
decrease. To refine the 1 mm Concentric Spiral as it currently stands, the channel should be made 
smaller (ex. 200 x 200 µm) and the number of turns (especially 180°) should be increased. These 
two alterations should both increase the WSS cells experience, by changing the geometric 
quantities W and h in Equation 1, and US exposure time, by increasing the length of the channel. 
The potential for decreasing the size of the channel is currently limited by current SLA 3D printing 
techniques, but it is very feasible to add additional spirals.  
Finally, the potential for sorting transformed cells, untransformed cells, and unruptured 
microbubbles by altering final curve and outlet geometry should be investigated. This could be 
accomplished by adding multiple smaller outlets spaced in some specific spatial orientation (ex. 
horizontally) that would capture the flow of particles of a certain density. Untransformed cells and 
unruptured microbubbles could be looped back into circulation to reduce the need for post-
processing separatory techniques and increase overall transformation efficacy. Especially if the 




to aid in the separation process. Like column chromatography, pulsatile flow at varying velocities 
could force different particles out of the channel at different times.  
Therefore, for present operations/experiments, the 1 mm Concentric Spiral should be used 
at greater flow rates with additional flow throughs; if possible, the geometry should be SLA printed 
at smaller diameters. These small alterations in the current procedures/setup should significantly 
increase the WSS and microbubble rupture stress that cells experience, which should continue to 
increase biologic delivery. It is important to keep in mind however, that too much shear exposure 
could adversely affect delivery results, so small, incremental changes in these parameters should 
be tested. While there are still improvements that can be made, based on the work presented here, 
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